Review ArticlesTowards a Saphenous Vein Graft MoratoriumMotwani, Ayush MD; Ayinapudi, Karnika MD; Singh, Twinkle MD; Maini, Rohit MD; Hendel, Robert MD; Le Jemtel, Thierry H. MDAuthor Information From the Division of Cardiology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA. Disclosure: The authors have no conflicts of interest to report. Correspondence: Thierry H. Le Jemtel, Tulane University Heart and Vascular Institute, 1430 Tulane Avenue, SL-48, New Orleans, LA 70112. E-mail: email@example.com. Cardiology in Review: September/October 2020 - Volume 28 - Issue 5 - p 236-239 doi: 10.1097/CRD.0000000000000277 Buy Metrics Abstract Atherosclerosis develops and rapidly progresses in saphenous veins grafts after coronary bypass surgery. In contrast to native coronary artery, percutaneous revascularization does not impede the progression of saphenous vein atherosclerosis and saphenous vein graft failure commonly ensues. The protracted patency of arterial grafts is likely to account for most of the long-term superiority of coronary artery bypass surgery over percutaneous revascularization in patients with complex coronary artery disease. Long-lasting, complete coronary revascularization may be best achieved by combining surgical arterial grafting of diseased coronary arteries to percutaneous revascularization with drug-eluting stents than by the continued use of saphenous vein grafts. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.